Yield Theory

Jefferson Shreve · JNJ

Jefferson Shreve's JNJ trades

Every Johnson & Johnson transaction Jefferson Shreve reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
2 / 1
Disclosed range
$80K – $200K
Last filed
2025-06-22

JNJ transactions reported by Jefferson Shreve

3 of 3 rows
TypeOwner
Johnson & Johnson Common Stock
JNJ
SaleSelf$50,001 - $100,0002025-06-22
#20030387
Johnson & Johnson Common Stock
JNJ
PurchaseSelf$15,001 - $50,0002025-04-11
#20029038
Johnson & Johnson Common Stock
JNJ
PurchaseSelf$15,001 - $50,0002025-03-09
#20027879

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Jefferson Shreve and JNJ — questions

Did Jefferson Shreve buy or sell JNJ?

House Clerk filings for 2025 and 2026 show 2 purchases and 1 sale of Johnson & Johnson (JNJ) reported by Jefferson Shreve, between 2025-02-24 and 2025-05-12. Reported owner: Self.

How much JNJ did Jefferson Shreve trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $80K – $200K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last JNJ filing by Jefferson Shreve?

The most recent periodic transaction report containing a JNJ row was filed on 2025-06-22. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Johnson & Johnson. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Jefferson Shreve JNJ disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included